Sort
1,049,261 grants matching “t cell”
Molecular mechanisms of hypoxia tolerance and susceptibility
$2,099,612Gabriel G Haddad · University Of California, San Diego · P01 · FY2012 · HL
Chemical Receptor Interactions In Reproduction And Hormonal Toxicity
$2,099,573Kenneth S Korach · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Single-nucleus transcriptome profiling across multiple brain regions in Parkinson's Disease
$2,099,553Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · NS
Studies of Populations Exposed to Occupational Sources of Radiation
$2,099,548Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Development of therapeutic pan-Alphavirus human monoclonal antibodies
$2,099,526Michael S. Diamond · La Jolla Institute For Immunology · U19 · FY2023 · AI
Vascular Inflammation and Atherosclerosis
$2,099,471University Of Rochester · P01 · FY2005 · HL
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$2,099,464Barton F Haynes · Duke University · U19 · FY2022 · AI
Post-transcriptional regulation of energy usage: glucose and lipid metabolism
$2,099,404Myriam Gorospe · National Institute On Aging · ZIA · FY2021 · AG
Institute for Biogenesis Research: COBRE
$2,099,380William S Ward · University Of Hawaii At Manoa · P20 · FY2014 · GM
DNA Vaccines
$2,099,304George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
APPARATUS FOR OPTIMIZING PHOTOVOLTAIC SOLAR MANUFACTURING EFFICIENCY THROUGH REAL-TIME PROCESS FEEDBACK AND SPECTRAL BINNING OF CELLS
$2,099,189Tau Science Corporation · · FY2012 · Department of Energy
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
$2,099,135Robert W Gereau · Washington University · UG3 · FY2020 · DA
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
$2,099,091Howard S. Fox · University Of Nebraska Medical Center · U01 · FY2023 · DA
CENTER FOR HUMAN CELL THERAPY
$2,099,035Leslie Eric Silberstein · Immune Disease Institute, Inc. · U24 · FY2007 · HL
MicroRNAs for therapy of visual disorders
$2,099,016Martin Friedlander · Scripps Research Institute, The · R24 · FY2015 · EY
Immunogenetics of Graft-Versus-Host Disease
$2,098,949Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2012 · CA
Immunogenetics of Graft-Versus-Host Disease
$2,098,949Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2016 · CA
Immunogenetics of Graft-Versus-Host Disease
$2,098,949Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
Developmental Trajectories of Negative Symptoms in Schizophrenia
$2,098,851Raquel E Gur · University Of Pennsylvania · P50 · FY2015 · MH
Boston Puerto Rican Health Study - CVD Risk Factors
$2,098,848Katherine L Tucker · University Of Massachusetts Lowell · P50 · FY2015 · HL
Advanced anthrax vaccine made with ISS DNA formulations
$2,098,735Gary A Van Nest · Dynavax Technologies Corporation · U01 · FY2006 · AI
Thymus biology
$2,098,689Yousuke Takahama · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Vascular Cell Signaling and Atherogenesis
$2,098,631Weill Medical College Of Cornell Univ · P01 · FY2004 · HL
Cell Autonomous and Non-Autonomous Mechanisms of Aging
$2,098,576Paul D. Robbins · Scripps Florida · P01 · FY2014 · AG
NEUROAIDS: EFFECTS OF METHAMPHETAMINE AND HCV
$2,098,449University Of California San Diego · P01 · FY2005 · DA